Rvl Pharmaceuticals Plc (NASDAQ: OSMT)
Some price data may be temporarily unavailable.
Rvl Pharmaceuticals Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Rvl Pharmaceuticals Plc Company Info
RVL Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. Its products include Upneeq, M-72, Arbaclofen ER, OS870, Divigel, OB Complete, Methylphenidate ER, Venlafaxine ER tablets (VERT), Hydromorphone ER, Sodium Benzoate/Sodium Phenylacetate, Oxybutynin ER, Prescription Prenatal Vitamins, Chlorzoxazone (Lorzone AG), Tramadol ER (ConZip AG), Nitrofurantoin and Osmodex ANDAs. The company was founded in 1986 and is headquartered in Bridgewater, NJ.
News & Analysis
Why Osmotica Pharmaceuticals Stock Plunged Today
One of the company's pipeline candidates ran into a regulatory hurdle.
Why Osmotica Pharmaceuticals Is Plunging Today
The company announced the pricing of a public offering of common stock.
Why Osmotica Pharmaceuticals Jumped Today
One of the company’s promising products was approved by the FDA.
These 2 Pharma Stocks Could Be Top Stocks in 2020
These pharma stocks are undervalued, and could be solid picks over the long term.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.